Berkshire Hathaway Filing May Reveal Warren Buffetts Tiny Purchase Teased in March Nvidia Data Center Revenue Nearly Doubles as Strong Earnings Report Prompts Stock Decline SpaceXs Potential SP Sector Classification Rockets Satellites and AI Integration Huawei Advances Chip Design Method Amid US Restrictions Plans New Smartphone Chips This Fall Paul McCartneys Final Appearance Highlights CBSs Financial Decision to End Colberts Late Show ParkerHannifin Acquires Circor Aerospace from KKR Reuters Reports CNH Q1 2026 Earnings EPS Surprises 754 Above Estimate Amid Challenging Environment BKD Q1 2026 Earnings EPS Misses Estimates as Senior Living Operator Navigates Cost Headwinds SPNT Q1 2026 Earnings Earnings Surpass Estimates by 178 Despite Slight Stock Decline VNOM Q1 2026 Earnings Strong Earnings Beat Highlights Operational Execution ELTK Q1 2026 Earnings Loss Per Share of 042 Shares Rise 608 Despite No Revenue Disclosure QMCO Q1 2026 Earnings Adjusted EPS Surprises to the Upside Despite Stock Decline abrdn Life Sciences Investors HQL Edges Higher as Sector Sentiment Stabilizes Gladstone Commercial Preferred GOODN Holds Steady Near Resistance as Yields Attract Income Investors Arbutus Biopharma ABUS Dips 2 Testing Key Support Levels Amid Modest Trading Volume Belden Inc BDC Holds Steady Near Midpoint as Trading Volume Remains Moderate Kronos Worldwide KRO Jumps 46 as Titanium Dioxide Sector Shows Signs of Life Inflation Pressures Mount as Americans Head into Memorial Day Weekend Rising Costs for Fuel Food and Travel Meta to Launch AI Subscription Service Trial Starting at 799 Per Month Standard Chartered Announces Significant Job Cuts in Corporate Functions to Boost Efficiency Oleksandr Usyk Vs Rico Verhoeven Start Time And Ring Walks In Egypt SpaceX Scrubs Starship Test Flight Reschedules for Friday Amid IPO BuildUp Retail Investors Gain Unprecedented Access to SpaceX IPO as Major Brokerages Open Doors Enterprise Products Partners Receives Higher Price Target as Analysts Remain Cautious on Outlook TPCS Q1 2026 Earnings Net Loss Reported Amid Limited Disclosures Oric Pharmaceuticals ORIC Holds Steady Near Key Support Levels Amidst Modest Gains